Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Thalamic Atrophy is Associated with Development of Clinically Definite Multiple Sclerosis.
The Arm Function in Multiple Sclerosis Questionnaire (AMSQ): development and validation of a new tool using IRT methods.
Oxidative stress-dependent phosphorylation activates ZNRF1 to induce neuronal/axonal degeneration.
Assessing fracture risk in people with MS: a service development study comparing three fracture risk scoring systems.
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients.
Marginal Structural Cox Models for Estimating the Association Between β-Interferon Exposure and Disease Progression in a Multiple Sclerosis Cohort.
CXCR7 suppression modulates microglial chemotaxis to ameliorate experimentally-induced autoimmune encephalomyelitis.
Impact of 24 Weeks of Resistance and Endurance Exercise on Glucose Tolerance in Persons with Multiple Sclerosis.
Enabling Precision Medicine With Digital Case Classification at the Point-of-Care.
Quantitative detection of epstein-barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis.
Deficits in memory and visuospatial learning correlate with regional hippocampal atrophy in MS.
The unfolded protein response in multiple sclerosis.
Biased Homozygous Haplotypes Across the Human Caveolin 1 Upstream Purine Complex in Parkinson's Disease.
The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice.
Obstructive sleep apnea is associated with fatigue in multiple sclerosis.
Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).
Carbon Monoxide and the Brain : Time to Rethink the Dogma.
Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach.
Neuroimaging of dementia.
Induction of Experimental Autoimmune Encephalomyelitis With Recombinant Human Myelin Oligodendrocyte Glycoprotein in Incomplete Freund's Adjuvant in Three Non-human Primate Species.
Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis.
Update on Disease-Modifying Treatments for Multiple Sclerosis.
Multiple sclerosis in Sistan and Baloochestan, South East Iran.
Seronegative NMO: A sensitive AQP4 antibody test clarifies clinical features and next challenges.
Epigenetic changes in inflammatory and autoimmune diseases.
Pages
« first
‹ previous
…
351
352
353
354
355
356
357
358
359
…
next ›
last »